ClassID:

112207

C12N2799/04 - CPC Classification

Classification description:

Uses of viruses as vector

Recent Application in this class:
#1
20250059563
2025-02-20

CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF

#2
20240352456
2024-10-24

COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES

#3
20230265452
2023-08-24

Phagemid Vector

#4
20210330816
2021-10-28

GENE THERAPY FOR OCULAR DISORDERS

#5
20200216861
2020-07-09

GENE THERAPY COMPOSITION FOR USE IN DIABETES TREATMENT

#6
20200148745
2020-05-14

Gene therapy vectors for treatment of Danon disease

#7
20200061209
2020-02-27

Gene therapy for ocular disorders

#8
20190365852
2019-12-05

RECOMBINANT BACULOVIRUSES AND USES THEREOF

#9
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

#10
20190119700
2019-04-25

Lentiviral vector capable of directly reflecting type I interferon response, preparation method thereof, and applications thereof

#11
20190000881
2019-01-03

Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes

#12
20180326016
2018-11-15

Treating glaucoma, cardiovascular diseases, and renal diseases

#13
20180320200
2018-11-08

Phagemid vector

#14
20180110848
2018-04-26

Measles virus encoding a tumor antigen

#15
20170275649
2017-09-28

Muscle-specific nucleic acid regulatory elements and methods and use thereof

#16
20170196960
2017-07-13

Method and compositions

#17
20170151313
2017-06-01

Lipid hydrolysis therapy for atherosclerosis and related diseases

#18
20160340693
2016-11-24

Muscle-specific nucleic acid regulatory elements and methods and use thereof

#19
20160143966
2016-05-26

Delivery of a therapeutic agent to the cerebral cortex by administering a viral vector by convection enhanced diffusion into the white matter of the brain

#20
20160074534
2016-03-17

Gene therapy composition for use in diabetes treatment

#21
20160022841
2016-01-28

Method for augmenting vision in persons suffering from photoreceptor cell degeneration

#22
20160008398
2016-01-14

Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes

#23
20150265690
2015-09-24

sporozoite and liver stage antigens

#24
20150111957
2015-04-23

Endothelial cell-specific polynucleotides and use thereof

#25
20140342982
2014-11-20

Gene therapy composition for use in diabetes treatment

#26
20140205652
2014-07-24

Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant

#27
20130058996
2013-03-07

Liposome containing shRNA molecule targeting a thymidylate synthase and use thereof

#28
20130030043
2013-01-31

Treating glaucoma, cardiovascular diseases, and renal diseases

#29
20120087940
2012-04-12

VECTOR FOR TREATING ALZHEIMER'S DISEASE

#30
20110319479
2011-12-29

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA

#31
20110269826
2011-11-03

Method

#32
20110256112
2011-10-20

Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein

#33
20110256101
2011-10-20

SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE

#34
20110213006
2011-09-01

Compositions and Methods for Treatment of Uncontrolled Cell Growth

#35
20110212073
2011-09-01

Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs

#36
20110172148
2011-07-14

Periostin-induced pancreatic regeneration

#37
20110129527
2011-06-02

RAB3B for treatment and prevention of Parkinson's disease

#38
20110129449
2011-06-02

COMPENSATING FOR ATRIOVENTRICULAR BLOCK USING A NUCLEIC ACID ENCODING A SODIUM CHANNEL OR GAP JUNCTION PROTEIN

#39
20110104195
2011-05-05

Plasmodium falciparum sporozoite and liver stage antigens

#40
20110082191
2011-04-07

METHOD FOR TREATING OR PREVENTING RADIATION DAMAGE BY IN VIVO GENE THERAPY

#41
20110008386
2011-01-13

Use of MVA to treat prostate cancer

#42
20100310517
2010-12-09

Methods of increasing collagen formation and cellular migration in intact skin

#43
20100304364
2010-12-02

Compositions and methods for monosynaptic transport

#44
20100298226
2010-11-25

POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA

#45
20100267806
2010-10-21

LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES

#46
20100239605
2010-09-23

Recombinant Rhinovirus Vectors

#47
20100239558
2010-09-23

Lipid Hydrolysis Therapy for Atherosclerosis and Related Diseases

#48
20100221811
2010-09-02

Recombinant adenovirus useful for treating malignancy over-expressing proto-oncogene neu/erb B2

#49
20100203627
2010-08-12

Long-term in vivo transgene expression

#50
20100178276
2010-07-15

Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes

#51
20100144659
2010-06-10

Targeting agent for cancer cell or cancer-associated fibroblast

#52
20100136654
2010-06-03

Method for transcription/degradation dual control of protein by antibiotic

#53
20100081707
2010-04-01

DEVICES AND METHODS FOR DELIVERING POLYNUCLEOTIDES INTO RETINAL CELLS OF THE MACULA AND FOVEA

#54
20100022628
2010-01-28

ALTERNATIVE OXIDASE AND USES THEREOF

#55
20090304765
2009-12-10

R-RAS activity in vascular regulation

#56
20090304588
2009-12-10

BIOLOGICALLY EXCITABLE CELLS

#57
20090297480
2009-12-03

Treating glaucoma, cardiovascular diseases, and renal diseases

#58
20090291087
2009-11-26

MODULATING ANGIOGENESIS

#59
20090123501
2009-05-14

INHIBITION OF THE SH2-DOMAIN CONTAINING PROTEIN TYR-PHOSPHATASE, SHP-1, TO ENHANCE VACCINES

#60
20090104232
2009-04-23

Compositions and methods for inhibiting infection

#61
20090104225
2009-04-23

Use of MVA to treat prostate cancer

#62
20090093429
2009-04-09

COMBINATION THERAPY FOR TREATING CANCER

#63
20090047294
2009-02-19

Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degeneration

#64
20080293830
2008-11-27

Method for activating efferent sympathetic nerves innervating adipose tissues to improve obesity and symptoms associated therewith

#65
20080234194
2008-09-25

GROWTH FACTOR MEDIATED COSMECEUTICALS AND USE THEREOF TO ENHANCE SKIN QUALITY

#66
20080226678
2008-09-18

Compositions for immunizing against mycobacterium

#67
20080193918
2008-08-14

Compositions and methods for monosynaptic transport

#68
20080103088
2008-05-01

Alternative oxidase and uses thereof

#69
20080031923
2008-02-07

Biologic Replacement for Fibrin Clot

#70
20070264249
2007-11-15

Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases

#71
20070213263
2007-09-13

Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis

#72
20070093434
2007-04-26

Regulation of food intake by modulation of long-chain fatty acyl-CoA levels in the hypothalamus

#73
20070086989
2007-04-19

Prosthetic Grafts

#74
20070082388
2007-04-12

Enhanced mediated DNA transfer

#75
20060281703
2006-12-14

Treatment of disease using an improved regulated expression system

#76
20060115829
2006-06-01

Method of treating a cancer

#77
20050277606
2005-12-15

Therapeutic methods and agents for diseases associated with decreased expression of AOP-1 gene or AOP-1

#78
20050271634
2005-12-08

Growth factor therapy mobilization of stem cells into the peripheral blood

#79
20050208022
2005-09-22

Method for augmenting vision in persons suffering from photoreceptor cell degeneration